Presentation by Laura Medford Davis for the Third Annual Policy Prescriptions® Symposium
Laura Medford-Davis is a Robert Wood Johnson clinical scholar at University of Pennsylvania and a practicing emergency physician.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
2. The Following Presenters Have Disclosed Relevant Financial Relationships:
Cedric Dark, MD MPH FAAEM FACEP
Community Health Choice, Event Sponsorship; Schumacher Clinical Partners, Event Sponsorship
Seth Trueger, MD MPH
Emergency Physicians Monthly, Employee, Salary
The Following Presenters Have Disclosed No Financial Relationships:
Megan Douglas, JD
Elena M. Marks, JD MPH
Laura Medford-Davis, MD
Bich-May Nguyen, MD MPH
The Following Planners Have Disclosed Relevant Financial Relationships:
Cedric Dark, MD MPH FAAEM FACEP
Community Health Choice, Event Sponsorship; Schumacher Clinical Partners,
Event Sponsorship
The Following Planning Committee Members and Staff Have Disclosed No
Relevant Financial Relationships:
Emily DeVillers, CAE
Kay Whalen, MBA CAE
Janet Wilson, CAE
I have nothing to disclose.
18. Evidence is Mixed
• Patients informed of MRI costs and options pre-MRI
– 18% cost reduction
• Employer offered a price transparency tool
– Tool used before 6% of claims
– Those who used it were more expensive pre-tool
– 14% cost reduction
• Employer offered a price transparency tool and
another did not
– 10% of employees used it
– $59 price increase
20. Best Practices for Transparency
• Estimates tailored to the patient, provider, and
insurance plan
– Specific prices, not averages, medians, or ranges
• Quality information
• Real-time availability
21. Problems with Current Transparency Tools
• Episodes not clearly defined
– CPT codes
• Limited number of services included
• Not linked to quality
• Hard to keep up-to-date with inflation and contract
changes
• Skewed by overutilization (and underutilization)
23. Barriers to Transparency
• Non-disclosure agreements
• Price protected under Trade Secrets
• Most-Favored Nation clauses
• Anti-tiering clauses
24. HCi3 – State Report Card on Price
Transparency Laws
25. 28 States Have Price Transparency Laws
• Allow states to collect information
• Require hospitals to disclose to the state
• Average charges or chargemasters
• Price disclosure upon request
26. States with Stronger Laws
• MA & WA: Insurance companies → Patients
• KS: Insurance companies → Providers
• CO: public all payer claims database
– Hospitals → Patients (average cost)
34. Dartmouth Atlas of Health Care
$219,591.42
$141,546.80
$119,526.19
$119,299.22
$117,916.27
$102,629.93
$99,255.48
$82,744.36
$77,528.25
$68,835.92
$42,120.81
$0.00
$50,000.00
$100,000.00
$150,000.00
$200,000.00
$250,000.00 1. Los Angeles Community Hospital
37. MD Anderson Cancer Center
97. Brigham & Womens
98. Hospital of the University of Pennsylvania
113. Park Plaza Hospital
266. St Lukes Episcopal
328. Memorial Hermann Medical Center
841. Cleveland Clinic
1093. Scott & White Memorial
1687. Geisinger
2074. Brookings (South Dakota)
42. Key Takeaways
• We have a lack of transparency in the USA
• Evidence on the benefits of transparency is mixed
• The majority of states have “policies” but most are
weak and ineffective
• Resources for cost comparisons exist, but most
provide averages or insurer-specific information